tradingkey.logo
搜索

TELA Bio Inc

TELA
添加自选
0.706USD
-0.034-4.65%
收盘 06/26, 16:00美东报价延迟15分钟
27.91M总市值
亏损市盈率 TTM

TELA Bio Inc

0.706
-0.034-4.65%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-4.65%

5天

-11.91%

1月

-21.63%

6月

-38.11%

今年开始到现在

-40.20%

1年

-64.18%

关键数据
0.720今开
0.778最高
272.28K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.69%换手率
0.740昨收
0.670最低
130.11K成交额
亏损市盈率静
1.54市净率
0.00%股息率 TTM
-54.15%ROA
2.20052周最高
1.68量比
-37.84M净利润
39.55M总股本
-0.7926每股收益TTM
1.30Beta
-616.62%ROE
0.50152周最低
14.54%振幅
65.69%毛利率
27.91M总市值
-4.23回报/风险
5.60%风险率

TradingKey TELA Bio Inc股票评分

单位: USD 更新时间: 2026-06-26

操作建议

TELA Bio Inc当前公司基本面数据相对健康,增长潜力较大。当前估值合理,在医疗设备与耗材行业排名100/203位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价2.25。中期看,股价处于上升通道。近一个月,市场表现非常差,但基本面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

TELA Bio Inc评分

相关信息

行业排名
100 / 203
全市场排名
247 / 4566
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

TELA Bio Inc亮点

亮点风险
TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, OviTex LPR, and OviTex IHR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.
业绩高增长
公司营业收入稳步增长,连续3年增长37.33%
业绩增长期
公司处于发展阶段,最新年度总收入80.28M美元
估值高估
公司最新PE估值-0.89,处于3年历史高位
机构减仓
最新机构持股32.85M股,环比减少15.76%
詹姆斯·西蒙斯持仓
明星投资者詹姆斯·西蒙斯持仓,最新持仓市值0.00
活跃度降低
近期活跃度降低,过去20天平均换手率-0.45

分析师目标

根据 5 位分析师
买入
评级
2.250
目标均价
+218.88%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

TELA Bio Inc简介

TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, OviTex LPR, and OviTex IHR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.
公司代码TELA
公司TELA Bio Inc
CEOKoblish (Antony)
网址https://www.telabio.com/

常见问题

TELA Bio Inc(TELA)的当前股价是多少?

TELA Bio Inc(TELA)的当前股价是 0.71。

TELA Bio Inc的股票代码是什么?

TELA Bio Inc的股票代码是TELA。

TELA Bio Inc股票的52周最高点是多少?

TELA Bio Inc股票的52周最高点是2.20。

TELA Bio Inc股票的52周最低点是多少?

TELA Bio Inc股票的52周最低点是0.50。

TELA Bio Inc的市值是多少?

TELA Bio Inc的市值是27.91M。

现在TELA Bio Inc(TELA)的股票是买入、持有还是卖出?

根据分析师评级,TELA Bio Inc(TELA)的总体评级为买入,目标价格为2.25。

TELA Bio Inc(TELA)股票的每股收益(EPS TTM)是多少

TELA Bio Inc(TELA)股票的每股收益(EPS TTM)是-0.83。
KeyAI